<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2025 (9) TMI 1083 - MADHYA PRADESH HIGH COURT</title>
    <link>https://www.taxtmi.com/caselaws?id=778594</link>
    <description>White Petroleum Jelly I.P. manufactured under a valid drug licence was treated as a medicament for VAT classification because its essential character, functional use, and specific statutory coverage under the drugs-and-medicines entry prevailed over any broader cosmetic or residuary entry. The classification authority was criticised for relying on over-the-counter sale, absence of prescription, and the seller&#039;s business profile, since those factors did not displace the product&#039;s therapeutic or protective character or the binding precedent on medicament classification. Once the product fell within the concessional drugs-and-medicines entry, the basis for the higher tax demand disappeared and interest linked to that differential demand was also not leviable.</description>
    <language>en-us</language>
    <pubDate>Thu, 11 Sep 2025 00:00:00 +0530</pubDate>
    <lastBuildDate>Fri, 19 Sep 2025 08:33:09 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=851668" rel="self" type="application/rss+xml"/>
    <item>
      <title>2025 (9) TMI 1083 - MADHYA PRADESH HIGH COURT</title>
      <link>https://www.taxtmi.com/caselaws?id=778594</link>
      <description>White Petroleum Jelly I.P. manufactured under a valid drug licence was treated as a medicament for VAT classification because its essential character, functional use, and specific statutory coverage under the drugs-and-medicines entry prevailed over any broader cosmetic or residuary entry. The classification authority was criticised for relying on over-the-counter sale, absence of prescription, and the seller&#039;s business profile, since those factors did not displace the product&#039;s therapeutic or protective character or the binding precedent on medicament classification. Once the product fell within the concessional drugs-and-medicines entry, the basis for the higher tax demand disappeared and interest linked to that differential demand was also not leviable.</description>
      <category>Case-Laws</category>
      <law>VAT / Sales Tax</law>
      <pubDate>Thu, 11 Sep 2025 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=778594</guid>
    </item>
  </channel>
</rss>